hyperprolactinemia
HYPERPROLACTINEMIA
Hyperprolactinemia is the presence of elevated prolactin levels that occurs in about one-thirds of patients w/ chronic kidney disease & resolves after successful transplantation.
It may cause visual field defects or headache in both men and women.
In women, signs and symptoms include menstrual irregularity, galactorrhea, infertility, vaginal dryness, dyspareunia, loss of libido and reduction in vertebral bone density (in sustained, pronounced hyperprolactinemia).
While in men, signs and symptoms include diminished libido, hypogonadism, gonadotrophin suppression, osteopenia, decreased muscle mass, and decreased facial hair that may occur in prolonged hyperprolactinemia.

Definition

  • Hyperprolactinemia is the presence of elevated prolactin levels

Etiology

Physiologic

  • Pregnancy
  • Lactation
  • Chest wall stimulation
  • Stress
  • Sleep
  • Coitus
  • Exercise

Drug-Induced

  • Dopamine receptor blockers
    • Thioxanthines
    • Phenothiazines eg Chlorpromazine, Perphenazine
    • Butyrophenones eg Haloperidol
    • Metoclopramide
  • Dopamine synthesis inhibitors
    • Methyldopa
  • Opiates & opiate antagonists
  • H2-receptor antagonists (H2RA) eg Cimetidine, Ranitidine
  • Catecholamine depletors
    • Reserpine
  • Imipramines eg Amitriptyline, Amoxapine
  • Hormones eg Estrogens
  • Ca antagonists
    • Verapamil
  • Selective serotonin reuptake inhibitor (SSRI)
    • Fluoxetine
  • Anesthetics
  • Anticonvulsants eg Phenytoin

Neurogenic Disorders

  • Lesions on the chest wall
  • Spinal cord injury
  • Stimulation of breast

Systemic Disorders

  • Hypothyroidism
  • Chronic renal failure (CRF)
  • Cirrhosis
  • Epileptic seizures
  • Polycystic ovarian disease
  • Pseudocyesis

Pituitary Hypersecretion

  • Acromegaly
  • Prolactinoma (most common cause of prolactin levels >100 mcg/L)
  • Macroprolactinemia
  • Plurihormonal adenoma
  • Macroadenoma (compressive)

Hypothalamic-Pituitary Stalk Damage

  • Tumors (eg craniopharyngoma, germinoma,
  • hypothalamic metastases, meningioma)
  • Empty sella
  • Adenoma w/ stalk compression
  • Lymphocytic hypophysitis
  • Rathke’s cyst
  • Irradiation
  • Trauma (eg pituitary stalk section, suprasellar surgery)
  • Granulomas
  • Infiltrations

Production of Ectopic Prolactin

  • Non-Hodgkin lymphoma
  • Colorectal adenocarcinoma
  • Renal cell carcinoma
  • Ovarian teratomas
  • Gonadoblastoma
  • Uterine cervical carcinoma

Signs and Symptoms

  • For both sexes, a pituitary tumor may cause visual field defects or headache

Women

  • Menstrual irregularity
  • Galactorrhea
  • Infertility
  • Vaginal dryness
  • Dyspareunia
  • Loss of libido
  • Reduction in vertebral bone mineral density in sustained, pronounced hyperprolactinemia

Men

  • Diminished libido
  • Visual loss caused by optic nerve compression
    • Extraocular muscle weakness
  • Hypogonadism
  • True galactorrhea is uncommon
  • Gonadotropin suppression
    • Reduced testosterone
    • Impotence
    • Oligospermia
  • Osteopenia, decreased muscle mass & decreased facial hair may occur in prolonged hyperprolactinemia
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
25 Aug 2015
At the Northern Pharmacists Convention cum 48th Malaysian Pharmaceutical Society Seminar 2015 held recently at Bayview Beach Hotel, Penang, Sanofi invited three distinguished speakers – Dr Khaw Chong Hui, Dr Lo Kang Shang Chit, and Professor Dr Karl-Josef Gundermann – to speak on the importance of renal protection in managing diabetic hypertension, the use of antihistamines in managing chronic urticaria (CU), and the role of essential phospholipids (EPL) in fatty liver diseases, respectively.
Roshini Claire Anthony, 07 Nov 2017

Women who are underweight, particularly in their late teens and mid-thirties, may be at risk for early menopause, a recent study found. 

16 Aug 2014

New drug applications approved by US FDA as of 15-30 Aug which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Audrey Abella, 20 Jan 2017
Diabetes was not a risk factor for total knee replacement (TKR) due to severe knee osteoarthritis, a Singapore study found.